WO1999024070A3 - Ester derivatives of hyaluronic acid with viscoelastic properties and their use in the biomedical and healthcare field - Google Patents

Ester derivatives of hyaluronic acid with viscoelastic properties and their use in the biomedical and healthcare field Download PDF

Info

Publication number
WO1999024070A3
WO1999024070A3 PCT/EP1998/007020 EP9807020W WO9924070A3 WO 1999024070 A3 WO1999024070 A3 WO 1999024070A3 EP 9807020 W EP9807020 W EP 9807020W WO 9924070 A3 WO9924070 A3 WO 9924070A3
Authority
WO
WIPO (PCT)
Prior art keywords
hyaluronic acid
biomedical
ester derivatives
viscoelastic properties
healthcare field
Prior art date
Application number
PCT/EP1998/007020
Other languages
French (fr)
Other versions
WO1999024070A2 (en
Inventor
Davide Renier
Alessandra Pavesio
Lanfranco Callegaro
Original Assignee
Fidia Advanced Biopolymers Srl
Davide Renier
Alessandra Pavesio
Lanfranco Callegaro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Advanced Biopolymers Srl, Davide Renier, Alessandra Pavesio, Lanfranco Callegaro filed Critical Fidia Advanced Biopolymers Srl
Priority to AU15598/99A priority Critical patent/AU1559899A/en
Publication of WO1999024070A2 publication Critical patent/WO1999024070A2/en
Publication of WO1999024070A3 publication Critical patent/WO1999024070A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Abstract

Viscoelastic compositions are described comprised of esters of hyaluronic acid which are uniquely advantageous because their viscoelastic characteristics may vary according to shearing stress and temperature.
PCT/EP1998/007020 1997-11-06 1998-11-05 Ester derivatives of hyaluronic acid with viscoelastic properties and their use in the biomedical and healthcare field WO1999024070A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU15598/99A AU1559899A (en) 1997-11-06 1998-11-05 Ester derivatives of hyaluronic acid with viscoelastic properties and their use in the biomedical and healthcare field

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97PD000253A IT1296689B1 (en) 1997-11-06 1997-11-06 ESTERE DERIVATIVES OF HYALURONIC ACID HAVING VISCOELASTIC PROPERTIES AND THEIR USE IN THE BIOMEDICAL-HEALTH FIELD
ITPD97A000253 1997-11-06

Publications (2)

Publication Number Publication Date
WO1999024070A2 WO1999024070A2 (en) 1999-05-20
WO1999024070A3 true WO1999024070A3 (en) 1999-07-15

Family

ID=11391956

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/007020 WO1999024070A2 (en) 1997-11-06 1998-11-05 Ester derivatives of hyaluronic acid with viscoelastic properties and their use in the biomedical and healthcare field

Country Status (3)

Country Link
AU (1) AU1559899A (en)
IT (1) IT1296689B1 (en)
WO (1) WO1999024070A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9144631B2 (en) 2003-01-27 2015-09-29 Benedicte Asius Ceramic-based injectable implants which are used to fill wrinkles, cutaneous depressions and scars, and preparation method thereof

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1302534B1 (en) * 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl INJECTABLE, BIOCOMPATIBLE AND BIODEGRADABLE COMPOSITIONS INCLUDING AT LEAST A DERIVATIVE OF HYALURONIC ACID, CHONDROGENIC CELLS, FOR
FR2794763B1 (en) * 1999-06-08 2001-08-24 Centre Nat Rech Scient NOVEL HYALURONIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE
EP1454640A3 (en) * 1999-10-15 2004-09-22 Genetics Institute, LLC Formulations of hyaluronic acid for delivery of osteogenic proteins
WO2001028602A1 (en) 1999-10-15 2001-04-26 Genetics Institute, Inc. Formulations of hyaluronic acid for delivery of osteogenic proteins
JP3848164B2 (en) * 2000-05-03 2006-11-22 フィディア・アドバンスト・バイオポリマーズ・ソシエタ・ア・レスポンサビリタ・リミタータ Biomaterial consisting of preadipocytes for soft tissue repair
CA2428066A1 (en) * 2000-11-06 2002-05-10 Kwan Y. Chan Non-aspirating transitional viscoelastics for use in surgery
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
US7820194B2 (en) 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
JP4879482B2 (en) 2002-05-17 2012-02-22 ワイス・エルエルシー Injectable solid hyaluronic acid carrier for delivering osteogenic proteins
US20100098772A1 (en) * 2008-10-21 2010-04-22 Allergan, Inc. Drug delivery systems and methods for treating neovascularization
IT1395392B1 (en) * 2009-08-27 2012-09-14 Fidia Farmaceutici VISCOELASTIC FROSTS LIKE NEW FILLERS
CN104725529A (en) * 2013-12-19 2015-06-24 上海建华精细生物制品有限公司 Hyaluronic acid derivative synthesis method
CZ2016827A3 (en) * 2016-12-23 2018-02-07 Contipro A.S. An ophthalmic preparation
IT201900019762A1 (en) * 2019-10-24 2021-04-24 Fidia Farm Spa Pharmaceutical composition for use in the treatment of cystitis of various etiology

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216453A2 (en) * 1985-07-08 1987-04-01 FIDIA S.p.A. Esters of hyaluronic acid and their salts.
EP0341745A1 (en) * 1988-05-13 1989-11-15 FIDIA S.p.A. Crosslinked carboxy polysaccharides
WO1996037519A1 (en) * 1995-05-22 1996-11-28 Fidia Advanced Biopolymers S.R.L. A polysaccharide hydrogel material, a process for its preparation and its use in medicine, surgery, cosmetics and for the preparation of health care products
WO1997049412A1 (en) * 1996-06-21 1997-12-31 Fidia S.P.A. Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216453A2 (en) * 1985-07-08 1987-04-01 FIDIA S.p.A. Esters of hyaluronic acid and their salts.
EP0341745A1 (en) * 1988-05-13 1989-11-15 FIDIA S.p.A. Crosslinked carboxy polysaccharides
WO1996037519A1 (en) * 1995-05-22 1996-11-28 Fidia Advanced Biopolymers S.R.L. A polysaccharide hydrogel material, a process for its preparation and its use in medicine, surgery, cosmetics and for the preparation of health care products
WO1997049412A1 (en) * 1996-06-21 1997-12-31 Fidia S.P.A. Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 9739, Derwent World Patents Index; Class B04, AN 97-418785, XP002102269 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9144631B2 (en) 2003-01-27 2015-09-29 Benedicte Asius Ceramic-based injectable implants which are used to fill wrinkles, cutaneous depressions and scars, and preparation method thereof

Also Published As

Publication number Publication date
ITPD970253A1 (en) 1999-05-06
ITPD970253A0 (en) 1997-11-06
IT1296689B1 (en) 1999-07-14
AU1559899A (en) 1999-05-31
WO1999024070A2 (en) 1999-05-20

Similar Documents

Publication Publication Date Title
WO1999024070A3 (en) Ester derivatives of hyaluronic acid with viscoelastic properties and their use in the biomedical and healthcare field
EP0265116A3 (en) Cross-linked esters of hyaluronic acid
MY127430A (en) Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols
AU7442398A (en) Glucosamine fatty acid compositions and their use
WO2000069449A3 (en) Conditioned cell culture medium compositions and methods of use
CA2282183A1 (en) Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
EP2085780A3 (en) Methods and products related to low molecular weight heparin
MY130670A (en) 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
MY121838A (en) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
WO2004012650A3 (en) Cosmetic or dermopharmaceutical compositions containing kombucha
WO2002039948A3 (en) Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants
WO1991005754A3 (en) Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same
DE69031732D1 (en) METHOD FOR PRODUCING GLYCOSIDE ESTERS AND COMPOSITIONS THEREOF
WO2001040240A3 (en) Mono- and disaccharide derivatives
BR0015133A (en) Mixtures of edible oils
BR9810121A (en) Use of native or esterified petroselinic acid
EP1219636A3 (en) Modified muteins of erythropoietin (EPO) derived from in vitro or in vivo expression system of microorganisms
CA2022177A1 (en) Arginine deiminase, its manufacturing method, and an anti-cancer agent containing this enzyme as an effective ingredient
WO2000030667A3 (en) Compositions and methods using lactadherin or variants thereof
AU3025795A (en) Compositions which are suitable for employment as antidotes to blood anticoagulants, and their use
DK1001007T3 (en) Sterol concentrates, use and preparation thereof
WO2003008457A3 (en) Polysaccharidic esters of retinoic acid
AU7958100A (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
AU2326399A (en) 12-hydroxy stearic acid esters, compositions based upon same and methods of using and making such compositions
WO1999038821A3 (en) Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA